New Key Statistics Module, Z-Score and F-Score
NAS:APLS Key Ratios
| Market Cap $ M | 5,756.60 |
| Enterprise Value $ M | 5,516.35 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 29.17 |
| Price/Sales | 14.32 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 396.00 |
| EPS (TTM) $ | -4.48 |
| Beneish M-Score | 1.51 |
| 10-y EBITDA Growth Rate % | -33.90 |
| 5-y EBITDA Growth Rate % | -13.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -11.10 |
| EV-to-EBITDA | -11.14 |
| PEG | -- |
| Shares Outstanding M | 121.29 |
| Net Margin (%) | -133.29 |
| Operating Margin % | -130.39 |
| Pre-tax Margin (%) | -132.76 |
| Quick Ratio | 2.50 |
| Current Ratio | 3.10 |
| ROA % (ttm) | -62.02 |
| ROE % (ttm) | -195.18 |
| ROIC % (ttm) | -300.53 |
| Dividend Yield % | -- |
| Altman Z-Score | -0.01 |
APLS Number of Guru Trades
APLS Volume of Guru Trades
Gurus Latest Trades with NAS:APLS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:APLS is held by these investors
Total 3
Apellis Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:APLS
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers